SLAUGIVITA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2022
From: 2021-09-01
To: 2022-08-31
|
2023
From: 2022-09-01
To: 2023-08-31
|
2024
From: 2023-09-01
To: 2024-08-31
|
2025
From: 2024-09-01
To: 2025-08-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 1,672,756 | 1,918,898 | 1,497,271 | 2,082,399 | 1,969,374 | 2,579,294 | 3,016,942 |
| Profit before tax | -14,807 | 37,994 | -22,891 | 58,146 | 6,635 | 159,144 | 142,202 |
| Net profit | -14,807 | 35,052 | -22,891 | 48,607 | 4,640 | 134,045 | 119,184 |
| Equity | 128,677 | 163,729 | 125,916 | 112,358 | 45,998 | 180,043 | 249,227 |
| Liabilities | 441,075 | 361,556 | 367,752 | 387,641 | 311,478 | 311,194 | 378,441 |
| Non-current assets | 39,132 | 31,273 | 23,610 | 59,354 | 90,041 | 90,711 | 85,392 |
| Current assets | 528,853 | 492,258 | 468,813 | 431,287 | 255,969 | 388,271 | 528,095 |
| Total assets | 567,985 | 523,531 | 492,423 | 490,641 | 346,010 | 478,982 | 613,487 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 291,646 | 356,801 | 429,963 |
| Social insurance contributions | - | - | - | - | 98,125 | 123,161 | 137,011 |
|
Financial indicators
|
|||||||
| Revenue change y/y | +8.5% | +14.7% | -22.0% | - | -5.4% | +31.0% | +17.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -2.6% | 6.7% | -4.6% | 9.9% | 1.3% | 28.0% | 19.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -11.5% | 21.4% | -18.2% | 43.3% | 10.1% | 74.5% | 47.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -0.9% | 1.8% | -1.5% | 2.3% | 0.2% | 5.2% | 4.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -0.9% | 2.0% | -1.5% | 2.8% | 0.3% | 6.2% | 4.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 3.4 | 2.2 | 2.9 | 3.5 | 6.8 | 1.7 | 1.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 104,006 | 106,605 | 78,460 | 120,719 | 119,962 | 153,226 | 155,379 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
SLAUGIVITA - Social security debts
The company had no debts to Sodra
SLAUGIVITA - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-28 | 2026-03-19 | 0.25 |
| 2026-02-21 | 2026-02-21 | 5.96 |
| 2025-05-19 | 2025-05-19 | 2524.03 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
SLAUGIVITA, UAB (code 145440368) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In financial year 2025, the company generated revenue of €3.02M and net profit of €119.2K, with a profit margin of 4.0%. Revenue increased by 17.0% year on year and by 53.2% over two years, showing a steady expansion from €1.97M in 2023 to €2.58M in 2024 and €3.02M in 2025. Net profit also improved materially from €4.6K in 2023 to €134.0K in 2024, before easing to €119.2K in 2025. At the end of 2025, total assets reached €613.5K, supported by equity of €249.2K and liabilities of €378.4K. The equity ratio stood at 40.6% and the debt-to-equity ratio at 1.52. Return on equity was 47.8% and return on assets 19.4%. Asset turnover was 4.92x, and revenue per employee was €158.8K, indicating efficient use of the asset base and workforce.